These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 9168064
1. Differences in CD34+ cell subpopulations between human bone marrow and "mobilized" peripheral blood as determined with counterflow centrifugal elutriation. Chang Q, Harvey K, Akard L, Thompson J, Dugan MJ, English D, Jansen J. Exp Hematol; 1997 May; 25(5):423-31. PubMed ID: 9168064 [Abstract] [Full Text] [Related]
4. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells. Preijers FW, van Hennik PB, Schattenberg A, Ruijs P, Ploemacher RE, de Witte T. Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074 [Abstract] [Full Text] [Related]
10. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow. De Bruyn C, Delforge A, Bron D, Bernier M, Massy M, Ley P, de Hemptinne D, Stryckmans P. Stem Cells; 1995 May; 13(3):281-8. PubMed ID: 7613494 [Abstract] [Full Text] [Related]
11. Comparison of the distribution of progenitor cells in G-CSF-mobilized peripheral blood and steady-state bone marrow after counterflow centrifugal elutriation. Chang Q, Harvey K, Akard L, Thompson J, Hanks S, Dugan M, Jansen J. Biol Blood Marrow Transplant; 1999 May; 5(5):328-35. PubMed ID: 10534064 [Abstract] [Full Text] [Related]
20. Fetal bone marrow CD34+CD41+ cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells. Murray LJ, Mandich D, Bruno E, DiGiusto RK, Fu WC, Sutherland DR, Hoffman R, Tsukamoto A. Exp Hematol; 1996 Feb; 24(2):236-45. PubMed ID: 8641347 [Abstract] [Full Text] [Related] Page: [Next] [New Search]